Adria Peguera-Bernat

Badalona, CT 08916, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

A rise in double-strand breaks sensitizes tumors to oxidative metabolism inhibitors.

A rise in double-strand breaks sensitizes tumors to oxidative metabolism inhibitors.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 09, 2026

Immune-based transcriptomic signature predicts CDK4/6 inhibitor efficacy in HR+/HER2- breast cancer.

Immune-based transcriptomic signature predicts CDK4/6 inhibitor efficacy in HR+/HER2- breast cancer.

Journal: Clinical and translational medicine

Published: May 20, 2025

Assessing the Prognostic Value of Cytoplasmic and Stromal Caveolin-1 in Early Triple-Negative Breast Cancer Undergoing Neoadjuvant Chemotherapy.

Assessing the Prognostic Value of Cytoplasmic and Stromal Caveolin-1 in Early Triple-Negative Breast Cancer Undergoing Neoadjuvant Chemotherapy.

Journal: International journal of molecular sciences

Published: September 17, 2024

Deciphering HER2-low breast cancer (BC): insights from real-world data in early stage breast cancer.

Deciphering HER2-low breast cancer (BC): insights from real-world data in early stage breast cancer.

Journal: Therapeutic advances in medical oncology

Published: July 13, 2024

Dual inhibition of MEK and PI3Kβ/δ-a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant metastatic prostate cancer.

Dual inhibition of MEK and PI3Kβ/δ-a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant metastatic prostate cancer.

Journal: Frontiers in pharmacology

Published: November 01, 2023

SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis.

SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis.

Journal: Frontiers in immunology

Published: November 30, 2022

Role of ctDNA in Breast Cancer.

Role of ctDNA in Breast Cancer.

Journal: Cancers

Published: December 17, 2021

Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: Preclinical and real-life clinical data.

Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: Preclinical and real-life clinical data.

Journal: Breast (Edinburgh, Scotland)

Published: November 17, 2021

FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma.

FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 20, 2020

PDGFR-induced autocrine SDF-1 signaling in cancer cells promotes metastasis in advanced skin carcinoma.

PDGFR-induced autocrine SDF-1 signaling in cancer cells promotes metastasis in advanced skin carcinoma.

Journal: Oncogene

Published: June 12, 2018

Cancer cell plasticity: Impact on tumor progression and therapy response.

Cancer cell plasticity: Impact on tumor progression and therapy response.

Journal: Seminars in cancer biology

Published: June 01, 2018

Cancer Stem-like Cells Act via Distinct Signaling Pathways in Promoting Late Stages of Malignant Progression.

Cancer Stem-like Cells Act via Distinct Signaling Pathways in Promoting Late Stages of Malignant Progression.

Journal: Cancer research

Published: June 15, 2015

Showing 1-12 of 12

Last Updated: 09/26/2026